WASHINGTON — A U.S. advisory panel has endorsed the brand new one-dose COVID-19 vaccine from Johnson & Johnson as a 3rd choice to bolster the nationwide effort in opposition to the coronavirus pandemic.
Advisers to the Facilities for Illness Management and Prevention voted overwhelmingly to advocate the vaccine for adults 18 years previous and up. The ruling adopted emergency clearance of the vaccine by U.S. regulators a day earlier.
Members of the group emphasised that each one three vaccines now accessible within the U.S. are extremely protecting in opposition to the worst results of the virus, together with hospitalization and loss of life.
J&J plans to ship a number of million vaccine doses to states within the coming week, delivering a complete of 20 million pictures by the top of March. Well being officers are wanting to have an easier-to-use vaccine in opposition to COVID-19, which has killed greater than 511,000 Individuals and continues to mutate in troubling methods.
CDC suggestions should not binding on state governments or medical doctors, however are extensively heeded by the medical neighborhood. The identical CDC panel beforehand really useful use of the 2 vaccines from Pfizer and Moderna approved in December.
Calling all HuffPost superfans!
Join membership to develop into a founding member and assist form HuffPost’s subsequent chapter